Why the study?
Does warfarin treatment reduce stroke or systemic thromboembolism and affect bleeding risk in patients with atrial fibrillation and chronic kidney disease?
Does warfarin treatment reduce stroke or systemic thromboembolism and affect bleeding risk in patients with atrial fibrillation and chronic kidney disease?
In patients with atrial fibrillation and chronic kidney disease, warfarin is associated with reduced stroke risk but increased bleeding risk, particularly when combined with aspirin.
Answers are grounded in this paper and cite their sources.
May inform anticoagulation decisions in AF-CKD but requires bleeding risk weighing, especially with aspirin; leaves open net benefit confirmation in RCTs.
Chronic kidney disease was associated with an increased risk of stroke or systemic thromboembolism and bleeding among patients with atrial fibrillation. Warfarin treatment was associated with a decreased risk of stroke or systemic thromboembolism among patients with chronic kidney disease, whereas warfarin and aspirin were associated with an increased risk of bleeding. (Funded by the Lundbeck Foundation.).
No takes yet. Share an insight, caveat, or question.
Olesen et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: